William Wong, MD
Dermatology · Aiea, HINPI 1457382772
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Sight Sciences, Inc. at 45.2% of the total. Reporting peaked in 2020 at $3,714 and has fallen 81.2% since, to $699 in 2025.
Across 221 payments — averaging $53.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sight Sciences, Inc.$5K
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$833
- LEO Pharma Inc.$823
- Amgen$525
- Arcutis Biotherapeutics, Inc.$350
- plus $3K from 21 others
What the payments were for
- Consulting fees$2,00017%
- Speaking & faculty fees$3,00025%
- Travel & lodging$2602%
- Food & beverage$6,48155%
- Education$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sight Sciences, Inc. | 6 | $5,321 |
| AbbVie | 48 | $1,247 |
| Regeneron Healthcare Solutions, Inc. | 17 | $833 |
| LEO Pharma Inc. | 39 | $823 |
| Amgen | 17 | $525 |
| Arcutis Biotherapeutics, Inc. | 14 | $350 |
| E.r. Squibb & Sons, L.L.C. | 14 | $341 |
| Incyte Corporation | 8 | $293 |
| UCB, Inc. | 4 | $267 |
| Sun Pharmaceutical Industries Inc. | 9 | $244 |
| Lilly USA, LLC | 9 | $232 |
| Novartis | 4 | $204 |
| Bausch & Lomb Americas Inc. | 1 | $144 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $134 |
| Glaukos Corporation | 1 | $125 |
| Sanofi | 4 | $108 |
| Pfizer | 4 | $92 |
| Strata Skin Sciences, Inc. | 5 | $82 |
| Hoffmann-la Roche Limited | 1 | $81 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $70 |
| Organon | 2 | $59 |
| Galderma Laboratories, L.p. | 2 | $52 |
| Johnson & Johnson | 2 | $48 |
| Biotissue Holdings Inc. | 1 | $35 |
| Oyster Point Pharma, Inc. | 1 | $30 |
| Bristol Myers Squibb | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,776 in reported general payments places this provider in the 80th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $84,600 |
| Betamethasone Dipropionate | 104 | $4,177 |
| Gentamicin Sulfate | 26 | $1,039 |
| Clobetasol Propionate | 12 | $799 |
| Triamcinolone Acetonide | 86 | $552 |
| Ketoconazole | 20 | $335 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $315 |
| Selenium Sulfide | 29 | $303 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Aiea
- Wayne FujitaAiea$385K
- Emily WongAiea$2K
- Jenifer FongAiea$998
- Mika YamazakiAiea$162
- George MartinKihei$2M
- Sarah HowellHonolulu$653K
- Douglas JohnsonHonolulu$568K
- Monica ScheelKailua Kona$253K
- Ryan SatoHonolulu$226K
- Rebecca LuriaKailua$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.